Evaluation of teicoplanin and vancomycin disk susceptibility tests
- 1 January 1986
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 23 (1) , 100-103
- https://doi.org/10.1128/jcm.23.1.100-103.1986
Abstract
Disk tests with two glycopeptide antibiotics, teicoplanin and vancomycin, were evaluated, and MICs were compared with those of fusidic acid and coumermycin. For tests with 30-micrograms vancomycin disks, we recommend modification of the current zone size standards to less than or equal to 10 mm for resistant and greater than or equal 15 mm for susceptible. For teicoplanin disk tests, 30-micrograms disks are recommended, with zone size interpretive standards of less than or equal to 10 and greater than or equal 14 mm. Since no resistant clinical isolates are available at this time, susceptibility testing of either drug is rarely necessary, and zone size standards are tentative.This publication has 9 references indexed in Scilit:
- Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. spAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity and human pharmacokinetics of teicoplaninAntimicrobial Agents and Chemotherapy, 1984
- Teicoplanin.1984
- In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1984
- Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin).The Journal of Antibiotics, 1984
- In vitro activity of teichomycin compared with those of other antibioticsAntimicrobial Agents and Chemotherapy, 1983
- Comparative in vitro activities of teichomycin and other antibiotics against JK diphtheroidsAntimicrobial Agents and Chemotherapy, 1983
- Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibioticsJournal of Antimicrobial Chemotherapy, 1983
- In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocciEuropean Journal of Clinical Microbiology & Infectious Diseases, 1982